242 results on '"Chan, Albert Chi-Yan"'
Search Results
2. Stage-by-stage analysis of the effect of blood transfusion on survival after curative hepatectomy for hepatocellular carcinoma—a retrospective study
3. Post-transplant inflammatory cytokine signature adds value for predicting tumor recurrence after liver transplantation for hepatocellular carcinoma
4. Dual-tracer PET/CT in the management of hepatocellular carcinoma
5. Sorted-Cell Sequencing on HCC Specimens Reveals EPS8L3 as a Key Player in CD24/CD13/EpCAM-Triple Positive, Stemness-Related HCC Cells
6. Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial
7. Impact of Three-Dimensional (3D) Visualization on Laparoscopic Hepatectomy for Hepatocellular Carcinoma
8. PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner
9. Magnetic resonance elastography and proton density fat fraction predict adverse outcomes in hepatocellular carcinoma
10. Impact of Time to Recurrence on Survival Outcome of Salvage Liver Transplantation
11. Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma.
12. Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma
13. Life long follow up and management strategies of patients living with native livers after Kasai portoenterostomy
14. Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis
15. Major postoperative complications compromise oncological outcomes of patients with intrahepatic cholangiocarcinoma after curative resection – A 13-year cohort in a tertiary center
16. Solitary extraovarian primary peritoneal carcinoma with direct invasion into the liver, diaphragm and lung without peritoneal dissemination or distant metastasis
17. Peer-to-peer clinical teaching by medical students in the formal curriculum
18. Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-alone in Unresectable Hepatocellular Carcinoma (HCC)
19. Validated nomogram for the prediction of disease-free survival after hepatectomy for hepatocellular carcinoma within the Milan criteria: individualizing a surveillance strategy
20. Risk prediction model for major complication after hepatectomy for malignant tumour - A validated scoring system from a university center
21. Impact of Hepatitis B Carrier Status on the Outcomes of Surgical Treatment of Colorectal Liver Metastases
22. Hepatocholangiocarcinoma/intrahepatic cholangiocarcinoma: are they contraindication or indication for liver transplantation? A propensity score-matched analysis
23. Association of Multi-Phasic MR-Based Radiomic and Dosimetric Features with Treatment Response in Unresectable Hepatocellular Carcinoma Patients following Novel Sequential TACE-SBRT-Immunotherapy
24. Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma: A meta-analysis
25. Impact of tumor biology on outcomes of radical therapy for hepatocellular carcinoma oligo-recurrence after liver transplantation
26. Verifying the benefits of radical treatment in posttransplant hepatocellular carcinoma oligo-recurrence: a propensity score analysis
27. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer
28. Efficacy of endoscopic self-expandable metal stent placement versus surgical bypass for inoperable pancreatic cancer-related malignant biliary obstruction: a propensity score-matched analysis
29. Sex‐specific analysis of microRNA profiles in HBV‐associated cirrhosis by small RNA‐sequencing
30. IDDF2022-ABS-0176 Tumor-derived iron loaded-exosomes impair CD8+ T anti-tumor ability via ferroptosis in hepatocellular carcinoma
31. Validated Nomogram for Prediction of Recurrence in HCC within Milan Criteria
32. Impact of Tumour Biology on Outcomes of Radical Therapy for Hepatocellular Carcinoma Oligo-Recurrence after Liver Transplantation
33. Criteria for liver transplantation in ACLF and outcome
34. Stanniocalcin 1 is a serum biomarker and potential therapeutic target for HBV ‐associated liver fibrosis
35. Erratum: Defining the role of laparoscopic liver resection in elderly HCC patients: a propensity score matched analysis
36. Combined Stereotactic Body Radiotherapy and Immunotherapy Versus Transarterial Chemoembolization in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
37. Verifying the Benefits of Radical Treatment in Posttransplant Hepatocellular Carcinoma Oligo‐recurrence: A Propensity Score Analysis
38. Durability of Small-for-Size Living Donor Allografts
39. Defining an optimal surgical strategy for synchronous colorectal liver metastases: staged versus simultaneous resection?
40. Impact of Time to Recurrence on Survival Outcome of Salvage Liver Transplantation
41. Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant
42. The ‘Unsigned highway’: An alternative route for portal vein anastomosis for non-malignant portal vein thrombosis during pediatric re-transplantation
43. Impact of three-dimensional (3D) visualization on laparoscopic hepatectomy for hepatocellular carcinoma
44. Liver transplantation: would it be the best and last chance of cure for hepatocellular carcinoma with major venous invasion?
45. Simultaneous portohepatic vein embolization a radiological: a short cut to associating liver partition and portal vein ligation for staged hepatectomy?
46. Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End‐Stage Liver Disease and Hepatorenal Syndrome
47. Prognostic value and reversibility of liver stiffness in patients undergoing tricuspid annuloplasty
48. Stretching the Limit of Native Liver Survival in Biliary Atresia After Kasai Portoenterostomy – a 37-year Territory-wide Study
49. RSK2-inactivating mutations potentiate MAPK signaling and support cholesterol metabolism in hepatocellular carcinoma
50. Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.